212 related articles for article (PubMed ID: 25583568)
1. A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.
Palmer AL; Diez P; Gandon L; Wynn-Jones A; Bownes P; Lee C; Aird E; Bidmead M; Lowe G; Bradley D; Nisbet A
Radiother Oncol; 2015 Feb; 114(2):264-71. PubMed ID: 25583568
[TBL] [Abstract][Full Text] [Related]
2. Design and implementation of a film dosimetry audit tool for comparison of planned and delivered dose distributions in high dose rate (HDR) brachytherapy.
Palmer AL; Lee C; Ratcliffe AJ; Bradley D; Nisbet A
Phys Med Biol; 2013 Oct; 58(19):6623-40. PubMed ID: 24018542
[TBL] [Abstract][Full Text] [Related]
3. End-to-end dosimetric audit: A novel procedure developed for Irish HDR brachytherapy centres.
Bassi S; Berrigan L; Zuchora A; Fahy L; Moore M
Phys Med; 2020 Dec; 80():221-229. PubMed ID: 33190078
[TBL] [Abstract][Full Text] [Related]
4. Verification of high dose rate brachytherapy dose distributions with EBT3 Gafchromic film quality control techniques.
Palmer AL; Nisbet A; Bradley D
Phys Med Biol; 2013 Feb; 58(3):497-511. PubMed ID: 23306148
[TBL] [Abstract][Full Text] [Related]
5. A multicentre 'end to end' dosimetry audit of motion management (4DCT-defined motion envelope) in radiotherapy.
Palmer AL; Nash D; Kearton JR; Jafari SM; Muscat S
Radiother Oncol; 2017 Dec; 125(3):453-458. PubMed ID: 29037776
[TBL] [Abstract][Full Text] [Related]
6. A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.
Awunor O; Berger D; Kirisits C
Med Phys; 2015 Aug; 42(8):4472-83. PubMed ID: 26233177
[TBL] [Abstract][Full Text] [Related]
7. Direct reconstruction and associated uncertainties of 192Ir source dwell positions in ring applicators using gafchromic film in the treatment planning of HDR brachytherapy cervix patients.
Awunor OA; Dixon B; Walker C
Phys Med Biol; 2013 May; 58(10):3207-25. PubMed ID: 23603854
[TBL] [Abstract][Full Text] [Related]
8. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
[TBL] [Abstract][Full Text] [Related]
10. Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy.
Andersen CE; Nielsen SK; Lindegaard JC; Tanderup K
Med Phys; 2009 Nov; 36(11):5033-43. PubMed ID: 19994514
[TBL] [Abstract][Full Text] [Related]
11. Radiochromic film dosimetry of rectal inhomogeneity and applicator attenuation in high dose rate brachytherapy of uterine cervix.
Uniyal SC; Naithani UC; Sharma SD; Srivastava AK
J Appl Clin Med Phys; 2012 Jan; 13(1):3654. PubMed ID: 22231217
[TBL] [Abstract][Full Text] [Related]
12. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
[TBL] [Abstract][Full Text] [Related]
13. Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system.
Mangold CA; Rijnders A; Georg D; Van Limbergen E; Pötter R; Huyskens D
Radiother Oncol; 2001 Jan; 58(1):43-51. PubMed ID: 11165681
[TBL] [Abstract][Full Text] [Related]
14. Comparison of traditional low-dose-rate to optimized and nonoptimized high-dose-rate tandem and ovoid dosimetry.
Decker WE; Erickson B; Albano K; Gillin M
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):561-7. PubMed ID: 11380246
[TBL] [Abstract][Full Text] [Related]
15. End-to-end dosimetry audit for three-dimensional image-guided brachytherapy for cervical cancer.
Mizuno H; Nakaji T; Fukuda S; Kato S
Phys Med; 2024 Mar; 119():103321. PubMed ID: 38394979
[TBL] [Abstract][Full Text] [Related]
16. A multicentre audit of HDR/PDR brachytherapy absolute dosimetry in association with the INTERLACE trial (NCT015662405).
Díez P; Aird EGA; Sander T; Gouldstone CA; Sharpe PHG; Lee CD; Lowe G; Thomas RAS; Simnor T; Bownes P; Bidmead M; Gandon L; Eaton D; Palmer AL
Phys Med Biol; 2017 Nov; 62(23):8832-8849. PubMed ID: 28984277
[TBL] [Abstract][Full Text] [Related]
17. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and implementation of triple-channel radiochromic film dosimetry in brachytherapy.
Palmer AL; Bradley D; Nisbet A
J Appl Clin Med Phys; 2014 Jul; 15(4):4854. PubMed ID: 25207417
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of PC-ISO for customized, 3D Printed, gynecologic 192-Ir HDR brachytherapy applicators.
Cunha JA; Mellis K; Sethi R; Siauw T; Sudhyadhom A; Garg A; Goldberg K; Hsu IC; Pouliot J
J Appl Clin Med Phys; 2015 Jan; 16(1):5168. PubMed ID: 25679174
[TBL] [Abstract][Full Text] [Related]
20. Australasian brachytherapy audit: results of the 'end-to-end' dosimetry pilot study.
Haworth A; Wilfert L; Butler D; Ebert MA; Todd S; Bucci J; Duchesne GM; Joseph D; Kron T
J Med Imaging Radiat Oncol; 2013 Aug; 57(4):490-8. PubMed ID: 23870350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
